was read the article
array:21 [ "pii" => "X0873215915364914" "issn" => "08732159" "doi" => "10.1016/j.rppnen.2015.04.003" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2015;21:233-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5371 "formatos" => array:3 [ "EPUB" => 228 "HTML" => 4030 "PDF" => 1113 ] ] "itemSiguiente" => array:16 [ "pii" => "X0873215915364922" "issn" => "08732159" "doi" => "10.1016/j.rppnen.2015.01.002" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2015;21:239-44" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4376 "formatos" => array:3 [ "EPUB" => 252 "HTML" => 3160 "PDF" => 964 ] ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Correlations between osteoprotegerin serum levels and body composition parameters in patients with sleep apnea syndrome and the possible influence on cardiovascular risk" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "239" "paginaFinal" => "244" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "320v21n05-90436492fig1.jpg" "Alto" => 1243 "Ancho" => 1625 "Tamanyo" => 142941 ] ] "descripcion" => array:1 [ "en" => "Differences in osteoprotegerin serum levels between OSA patients with cardiovascular disease (CVD) and OSA without CVD. Abbreviations: SEM, standard error of the mean; SD, standard deviation." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Kosacka, P. Piesiak, I. Porebska, R. Jankowska" "autores" => array:4 [ 0 => array:2 [ "Iniciales" => "M." "apellidos" => "Kosacka" ] 1 => array:2 [ "Iniciales" => "P." "apellidos" => "Piesiak" ] 2 => array:2 [ "Iniciales" => "I." "apellidos" => "Porebska" ] 3 => array:2 [ "Iniciales" => "R." "apellidos" => "Jankowska" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915364922?idApp=UINPBA00004E" "url" => "/08732159/0000002100000005/v0_201604141143/X0873215915364922/v0_201604141143/en/main.assets" ] "itemAnterior" => array:16 [ "pii" => "X0873215915364906" "issn" => "08732159" "doi" => "10.1016/j.rppnen.2015.07.001" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2015;21:230-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4033 "formatos" => array:3 [ "EPUB" => 260 "HTML" => 2797 "PDF" => 976 ] ] "en" => array:7 [ "idiomaDefecto" => true "titulo" => "Portugal at the cross road of international chronic respiratory programmes" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "230" "paginaFinal" => "232" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915364906?idApp=UINPBA00004E" "url" => "/08732159/0000002100000005/v0_201604141143/X0873215915364906/v0_201604141143/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S2173511515001487" "issn" => "21735115" "doi" => "10.1016/j.rppnen.2015.08.001" "estado" => "S300" "fechaPublicacion" => "2015-09-01" "aid" => "1084" "copyright" => "Sociedade Portuguesa de Pneumologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "edi" "cita" => "Rev Port Pneumol. 2015;21:227-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1738 "formatos" => array:3 [ "EPUB" => 244 "HTML" => 977 "PDF" => 517 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Impaired function in the complex patient with COPD: a matter to be considered" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "227" "paginaFinal" => "229" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 966 "Ancho" => 2296 "Tamanyo" => 67191 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Relationship between number of the (considered) comorbidities and functional impairment as assessed by health status CAT score (from ref#11).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. Tonelli, E.M. Clini" "autores" => array:2 [ 0 => array:2 [ "nombre" => "R." "apellidos" => "Tonelli" ] 1 => array:2 [ "nombre" => "E.M." "apellidos" => "Clini" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511515001487?idApp=UINPBA00004E" "url" => "/21735115/0000002100000005/v3_201605090007/S2173511515001487/v3_201605090007/en/main.assets" ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Exercise capacity impairment in COPD patients with comorbidities" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "233" "paginaFinal" => "238" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "G.P.F. Da Silva, M.T.A. Pessoa Morano, A.G. De Matos Cavalcante, N.M. De Andrade, E. De Francesco Daher, E.D.B. Pereira" "autores" => array:6 [ 0 => array:3 [ "nombre" => "G.P.F." "apellidos" => "Da Silva" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 1 => array:3 [ "nombre" => "M.T.A. Pessoa" "apellidos" => "Morano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] 2 => array:3 [ "nombre" => "A.G. De Matos" "apellidos" => "Cavalcante" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "Iniciales" => "N.M." "apellidos" => "De Andrade" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "nombre" => "E. De Francesco" "apellidos" => "Daher" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 5 => array:4 [ "nombre" => "E.D.B." "apellidos" => "Pereira" "email" => array:1 [ 0 => "eanes@fortalnet.com.br" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor1" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Universidade Federal do Ceará – UFC, Fortaleza, Brazil" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Universidade de Fortaleza – UNIFOR, Fortaleza, Brazil" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 2 => array:3 [ "entidad" => "Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Brazil" "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "<span class="elsevierStyleSup">*</span>" "correspondencia" => "Corresponding author. eanes@fortalnet.com.br" ] ] ] ] "textoCompleto" => "<a name="sec0005" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Introduction</span><p class="elsevierStylePara">Chronic obstructive pulmonary disease (COPD) is an important cause of impaired health-related quality of life, disability and death, with expressive social and economic repercussions.<a href="#bib34" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">1</span></a> It is a complex disease with pulmonary and systemic symptoms, frequently associated with comorbidities<a href="#bib35" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">2</span></a> that contribute to reduced health status and increased healthcare utilization, all-cause hospital admission, and mortality.<a href="#bib36" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">3</span></a><span class="elsevierStyleSup">, </span><a href="#bib37" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">4</span></a> The prevalence of the different types of comorbidity varies somewhat across studies, depending on the patient population, the definition of diseases and methods of patient evaluation.<a href="#bib38" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">5</span></a></p><p class="elsevierStylePara">Hypertension, coronary disease and diabetes are frequent conditions associated with COPD and an increased risk of death.<a href="#bib39" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">6</span></a><span class="elsevierStyleSup">, </span><a href="#bib40" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">7</span></a> The presence of these comorbidities appears to have a deleterious effect on several outcomes in COPD.<a href="#bib38" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">5</span></a></p><p class="elsevierStylePara">Endothelial dysfunction and increased arterial stiffness begin early in the course of COPD<a href="#bib41" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">8</span></a><span class="elsevierStyleSup">, </span><a href="#bib42" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">9</span></a><span class="elsevierStyleSup">, </span><a href="#bib43" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">10</span></a> and probably represent the onset of atherosclerotic disease. Data from one study, including 20,269 subjects, identified a 40% prevalence of hypertension among 76 patients with COPD.<a href="#bib40" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">7</span></a> Results from an observational study suggests that poorer health status, as indicated by a high COPD assessment test (CAT) score, may indicate the presence of certain comorbidities.<a href="#bib44" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">11</span></a></p><p class="elsevierStylePara">There is a growing body of evidence from some studies evaluating the impact of comorbidities on 6-min walking test (6MWT). Most of these studies have included patients with anxiety and depression.<a href="#bib45" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">12</span></a><span class="elsevierStyleSup">, </span><a href="#bib46" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">13</span></a><span class="elsevierStyleSup">, </span><a href="#bib47" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">14</span></a><span class="elsevierStyleSup">, </span><a href="#bib48" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">15</span></a> Only one observational and longitudinal study has included 2164 patients with COPD associated with diabetes and cardiovascular disease.<a href="#bib49" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">16</span></a></p><p class="elsevierStylePara">A better understanding of the impact of comorbidities, particularly diabetes, hypertension and cardiovascular disease, among patients with COPD is required. In the current study, we have evaluated the impact of comorbidities, diabetes, hypertension and cardiovascular disease, on functional performance in patients with COPD, after controlling for the effects of potential confounders including age, severity of COPD and health status.</p><a name="sec0010" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Methods</span><a name="sec0015" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Patients and study design</span><p class="elsevierStylePara">A cross-sectional study was conducted at two teaching hospitals in Fortaleza, Brazil, from January to December 2012. The research protocol was approved by local Research Ethics Committee (no. 880/12), and a written informed consent was obtained in all 96 cases. Patients were recruited during their initial assessment prior to enrollment in a 97 pulmonary rehabilitation program in the ambulatories of both hospitals. The inclusion criteria were, to be smoker or ex-smoker with a smoking history of at least 10 packs-years, aged 40–80 years, a previous diagnosis of COPD on stages II–IV (post-bronchodilator FEV1/FVC < 0.7 and FEV1 < 80% of predicted). All patients were clinically stable and without exacerbations for at least one month prior to recruitment.</p><p class="elsevierStylePara">Patients with a primary diagnosis of asthma or other chronic respiratory diseases, with severe cognitive deficiency preventing them from understanding the questionnaire and patients with restricted mobility, were excluded.</p><a name="sec0020" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Assessment of patient's parameters</span><p class="elsevierStylePara">Socio-demographic data were obtained through a structured questionnaire. Functional capacity was assessed by spirometry and 6MWT. The time allowed for patients to rest between the two tests was 1 h.</p><p class="elsevierStylePara">Spirometry was conducted using an electronic spirometer in accordance with the guidelines of the American Thoracic Society/European Respiratory Society (ATS/ERS).<a href="#bib50" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">17</span></a></p><p class="elsevierStylePara">Functional exercise capacity was assessed by 6MWT. It was performed twice in a 30 m corridor. The patients were instructed to walk from end to end, covering as much ground as they could during the allotted time, as recommended by ATS guidelines.<a href="#bib51" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">18</span></a></p><p class="elsevierStylePara">Health-related quality of life was assessed by St. George's respiratory questionnaire (SGRQ). The SGRQ consists of 53 items, which can be aggregated into an overall score and three domain scores describing symptoms, activity and impact.<a href="#bib52" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">19</span></a> Current health was assessed by the COPD assessment test (CAT). This questionnaire consists of eight items that describe cough, phlegm, chest tightness, breathlessness going up hills/stairs, activity limitations at home, confidence leaving home, sleep and energy. Each item is scored from 0 to 5, thereby making the range of the total score from 0 to 40. Higher scores represent worse health.<a href="#bib53" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">20</span></a> Both, SGRQ and CAT were previously translated and validated for the Portuguese language.<a href="#bib54" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">21</span></a><span class="elsevierStyleSup">, </span><a href="#bib55" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">22</span></a><span class="elsevierStyleSup">, </span><a href="#bib56" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">23</span></a> The Brazilian version of SGRQ and CAT showed good psychometric properties. CAT showed an excellent inter-rater and intra-rater reliability (intraclass correlation coefficient [ICC] = 0.96; 95% CI: 0.93–0.97; <span class="elsevierStyleItalic">p</span> < 0.001; and ICC = 0.98; 95% CI: 0.96–0.98; <span class="elsevierStyleItalic">p</span> < 0.001, respectively).<a href="#bib56" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">23</span></a> SGRQ showed an intraclass correlation ratio for the total score of <span class="elsevierStyleItalic">α</span> = 0.79.<a href="#bib54" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">21</span></a> Both questionnaires were administered in the mode of face-to-face interview, by the same interviewer and prior to the start of the rehabilitation program.</p><p class="elsevierStylePara">The diagnosis of the three studied comorbidities was based on data from medical records or upon clinical examination of patients. Subjects were classified as having diabetes if they reported a physician diagnosis of diabetes at baseline, or had impaired fasting or post-glucose load glucose levels (≥140 mg dL<span class="elsevierStyleSup">−1</span>) upon examination.</p><p class="elsevierStylePara">Subjects were classified as having coronary disease if they reported a previous physician diagnosis of myocardial infarction, angina or transient ischemic attacks, or when this information was registered in their medical records.</p><p class="elsevierStylePara">Subjects were classified as having hypertension if they reported a physician diagnosis of hypertension, were taking drugs for hypertension or had evidence of hypertension during a clinical examination (diastolic blood pressure ≥90 mmHg or a systolic blood pressure ≥140 mmHg, on three measurements). Each subject was classified as having none, one, two or three comorbidities.</p><a name="sec0025" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Statistical analyses</span><p class="elsevierStylePara">For continuous variables, data are presented as means ± standard deviation (SD) and for categorical variables, as percentage. Normality distribution for continuous variables was assessed by means of the Kolmogorov–Smirnov test. One-way ANOVA with the Bonferroni correction was used to compare the means of the three groups. For comparison of proportions, the χ<span class="elsevierStyleSup">2</span> test for linear trends was used. A multiple linear regression was run to predict the impact of comorbidities on 6MWT adjusting for age, severity of COPD and CAT scores. The <span class="elsevierStyleItalic">p</span> values less than 0.05 were considered significant. All statistical analyses were performed with SPSS for Windows version 10.0 (SPSS Inc., Chicago, IL).</p><a name="sec0030" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Results</span><p class="elsevierStylePara">Demographic, clinical, respiratory function and functional exercise capacity of the 79 subjects studied are shown in <a href="#t0005" class="elsevierStyleCrossRefs">Table 1</a>. According the new GOLD classification (GOLD 2014),<a href="#bib57" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">24</span></a> 4 (5%) patients were in grade A, 26 (32.9%) in grade B, 7 (8.8%) in grade C and 42 (53%) in grade D.</p><p class="elsevierStylePara">Table 1. Demographic, clinical and functional characteristics of 79 COPD patients.</p><a name="t0005" class="elsevierStyleCrossRefs"></a><p class="elsevierStylePara"></p><table><tr align="left"><td>Variable</td><td>COPD patients (79)</td></tr><tr align="left"><td colspan="2">Gender no (%)</td></tr><tr align="left"><td>Male</td><td>44 (56%)</td></tr><tr align="left"><td>Female</td><td>35 (44%)</td></tr><tr align="left"><td>Age, years mean ± SD</td><td>67 ± 8</td></tr><tr align="left"><td colspan="2"> </td></tr><tr align="left"><td colspan="2">COPD classification <span class="elsevierStyleItalic">n</span> (%)</td></tr><tr align="left"><td>Grade A</td><td>4 (5%)</td></tr><tr align="left"><td>Grade B</td><td>26 (32.9%)</td></tr><tr align="left"><td>Grade C</td><td>7 (8.8%)</td></tr><tr align="left"><td>Grade D</td><td>42 (53%)</td></tr><tr align="left"><td>FEV1 (%) mean ± SD</td><td>45.5 ± 13.2</td></tr><tr align="left"><td>FEV1 (l) mean ± SD</td><td>1.06 ± 0.377</td></tr><tr align="left"><td>FVC (%) mean ± SD</td><td>73.1 ± 16.5</td></tr><tr align="left"><td>FVC (l) mean ± SD</td><td>2.17 ± 0.694</td></tr><tr align="left"><td colspan="2"> </td></tr><tr align="left"><td colspan="2">SGRQ mean ± SD</td></tr><tr align="left"><td>Total mean ± SD</td><td>49.4 ± 18</td></tr><tr align="left"><td>Symptoms mean ± SD</td><td>45.5 ± 22.9</td></tr><tr align="left"><td>Activity mean ± SD</td><td>61 ± 23.1</td></tr><tr align="left"><td>Impact mean ± SD</td><td>41.7 ± 19.8</td></tr><tr align="left"><td>6MWT meters, mean ± SD</td><td>355 ± 93.8</td></tr><tr align="left"><td colspan="2"> </td></tr><tr align="left"><td colspan="2">Comorbidities</td></tr><tr align="left"><td>Total</td><td>43 (54%)</td></tr><tr align="left"><td>Hypertension</td><td>39 (49%)</td></tr><tr align="left"><td>Diabetes</td><td>14 (17%)</td></tr><tr align="left"><td>Coronary disease</td><td>19 (24%)</td></tr><tr align="left"><td colspan="2"> </td></tr><tr align="left"><td colspan="2">Numbers of comorbidity</td></tr><tr align="left"><td>zero</td><td>36 (45%)</td></tr><tr align="left"><td>One</td><td>19 (24%)</td></tr><tr align="left"><td>Two or three</td><td>24 (30%)</td></tr></table><p class="elsevierStylePara">The mean age of the patients was 67 ± 8 years and 44 (55%) were male. Fifty four percent of patients had at least one of three studied comorbidities. The sample was stratified as having “none”, “one” and “two or three” comorbidities groups. There was a significant difference between groups as determined by one-way ANOVA (<a href="#t0010" class="elsevierStyleCrossRefs">Table 2</a>). CAT scores increased from the “none” comorbidity group (17.9 ± 7.7) to “one” comorbidity group (22.8 ± 6.8) and “two or three” comorbidities group (24.2 ± 10.2). A Bonferroni post hoc test revealed a significant difference in the “none” comorbidity group compared to the “two or three” comorbidities group (<span class="elsevierStyleItalic">p</span> = 0.01).</p><p class="elsevierStylePara">Table 2. Parameters of the 79 patients according to the number of comorbidity.</p><a name="t0010" class="elsevierStyleCrossRefs"></a><p class="elsevierStylePara"></p><table><tr align="left"><td>Variable</td><td>Zero (36)</td><td>One (19)</td><td>Two or three (24)</td><td><span class="elsevierStyleItalic">p</span></td></tr><tr align="left"><td>Male no. (%) <span class="elsevierStyleSup">*</span></td><td>23 (33)</td><td>10 (52)</td><td>11 (45)</td><td>0.3</td></tr><tr align="left"><td>Age, years mean ± SD <span class="elsevierStyleSup">c</span></td><td>65.3 ± 7.5</td><td>68.6 ± 8.6</td><td>68.2 ± 8.2</td><td>0.3</td></tr><tr align="left"><td colspan="5"> </td></tr><tr align="left"><td colspan="5">Severity of airflow limitation no. (%) <span class="elsevierStyleSup">*</span></td></tr><tr align="left"><td>Stage II</td><td>18 (50)</td><td>7 (36)</td><td>7 (29)</td><td>0.2</td></tr><tr align="left"><td>Stage III/IV</td><td>18 (50)</td><td>12 (63)</td><td>1 (70)</td><td> </td></tr><tr align="left"><td colspan="5"> </td></tr><tr align="left"><td colspan="5">SGRQ mean ± SD <span class="elsevierStyleSup">c</span></td></tr><tr align="left"><td>Total</td><td>49.7 ± 18.1</td><td>49.9 ± 19.6</td><td>48.6 ± 19.7</td><td>0.9</td></tr><tr align="left"><td>Symptoms</td><td>44.7 ± 24.5</td><td>46.7 ± 20.4</td><td>45.9 ± 23.7</td><td>0.8</td></tr><tr align="left"><td>Activity</td><td>62.3 ± 21.9</td><td>61.7 ± 21.2</td><td>51.5 ± 21.4</td><td>0.9</td></tr><tr align="left"><td>Impact</td><td>42 ± 18.5</td><td>41.3 ± 18.6</td><td>41.6 ± 21.1</td><td>0.9</td></tr><tr align="left"><td>mMrc</td><td>2.1</td><td>2.1</td><td>2.8</td><td>0.3</td></tr><tr align="left"><td>6MWT meters, mean ± SD <span class="elsevierStyleSup">c</span></td><td>386.1 ± 83.2 <span class="elsevierStyleSup">a</span></td><td>350 ± 98</td><td>312.6 ± 91</td><td>0.007</td></tr><tr align="left"><td>CAT scores <span class="elsevierStyleSup">c</span></td><td>17.9 ± 7.7 <span class="elsevierStyleSup">b</span></td><td>22.8 ± 6.8</td><td>24.2 ± 10.2</td><td>0.019</td></tr></table><p class="elsevierStylePara">SGRQ: St. George's respiratory questionnaire, mMRC: modified medical research council dyspnea scale, 6MWT: 6-min walking test, CAT: COPD assessment test.<br></br></p><p class="elsevierStylePara">* <span class="elsevierStyleItalic">χ</span><span class="elsevierStyleSup">2</span> test for linear trends.<br></br>a Significant difference between groups: no comorbidities vs more than 1 comorbidity.<br></br>b Significant difference between groups: no comorbidities vs more than 1 comorbidity.<br></br>c Analysis of variance with Bonferroni correction.<br></br></p><p class="elsevierStylePara">The presence of comorbidities was associated with an increased CAT score for the items that assess the functional capacity. The score of activities items increased from 2.56 ± 1.4 for “none” comorbidity group to 3.32 ± 1.2 for “one” comorbidity group and 3.38 ± 1.5 for “two or three” comorbidities group (<span class="elsevierStyleItalic">p</span> = 0.04). For confidence and energy items the scores for groups “none”, “one” and “two or three” comorbidities were respectively 2.03 ± 1.1; 2.63 ± 1.2 and 3.04 ± 1.5 (<span class="elsevierStyleItalic">p</span> = 0.01) and 2.78 ± 1.2; 3.58 ± 1.1 and 3.67 ± 1.4 (<span class="elsevierStyleItalic">p</span> = 0.02).</p><p class="elsevierStylePara">The distance walked by the patients decreased from the “none” comorbidity group (386.1 ± 83.2 m) to the “one” comorbidity group (350 ± 98 m) and “two or three” comorbidities group (312.6 ± 91 m). A Bonferroni post hoc test showed significant difference in the “none” comorbidity group compared to “two or three” comorbidities group (<span class="elsevierStyleItalic">p</span> = 0.007).</p><p class="elsevierStylePara">Each one of the three specific comorbidities had a similar impact on both exercise functional capacity as in CAT score. For cardiovascular disease, hypertension or diabetes the distance walked by the patients was respectively, 315 ± 95.4 m, 330 ± 98.2 m and 313.8 ± 80.7 m (<span class="elsevierStyleItalic">p</span> < 0.05). The CAT scores were respectively, 23.7 ± 10.5; 23.4 ± 9.2 and 22.6 ± 9.7 (<span class="elsevierStyleItalic">p</span> < 0.05). Multiple linear regression analyses was built in order to investigate the influence of comorbidities on the 6MWT adjusting for age, severity of COPD and CAT scores A multiple linear regression model was built in order to investigate the influence of comorbidities in the 6MWT, after adjustment for age, severity of COPD and CAT score. The number of comorbidities was inversely associated with the distance walked during the 6MWT (<a href="#t0015" class="elsevierStyleCrossRefs">Table 3</a>).</p><p class="elsevierStylePara">Table 3. Results of the stepwise multiple regression analyses of 79 patients with 6MWT as dependent variable.</p><a name="t0015" class="elsevierStyleCrossRefs"></a><p class="elsevierStylePara"></p><table><tr align="left"><td>Outcome/predictor</td><td>Coefficient</td><td>Standard error</td><td><span class="elsevierStyleItalic">p</span>-value</td><td>95% CI</td></tr><tr align="left"><td colspan="5">6MWT</td></tr><tr align="left"><td>Constant</td><td>520.5</td><td>101.6</td><td>0.000</td><td>318.7 to 722.4</td></tr><tr align="left"><td>No. of comorbidities</td><td>−23.5</td><td>10.9</td><td>0.03</td><td>−45.4 to −1.7</td></tr></table><p class="elsevierStylePara">Adjusted <span class="elsevierStyleItalic">R</span><span class="elsevierStyleSup">2</span> = 0.117.<br></br>6MWT: 6-min walking test.<br></br></p><a name="sec0035" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Discussion</span><p class="elsevierStylePara">In this cross-sectional study, we found that 54% of patients with COPD, before starting the pulmonary rehabilitation program, had at least one of the three searched comorbidities. In a previous study, Crisafulli et al. reported very similar results (51%).<a href="#bib58" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">25</span></a></p><p class="elsevierStylePara">The exercise capacity is currently considered an important parameter in the prediction of the risk of death from any cause and from respiratory causes among patients with COPD.<a href="#bib59" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">26</span></a> This study showed that the presence of one or more comorbidities is associated with reduced exercise capacity in COPD patients. Our findings corroborated a recent study showing that heart trouble, hypertension and diabetes are associated with increased breathlessness and reduced 6-min walking distance.<a href="#bib49" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">16</span></a> The assessment of exercise capacity by means of the 6MWT is frequently used in pulmonary and cardiac diseases. This is a simple, low cost and reproducible method to assess exercise capacity and it correlates closely with the daily activities of patients.<a href="#bib60" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">27</span></a></p><p class="elsevierStylePara">Several comorbidities are associated with COPD. Among the frequently considered as relevant are included cardiovascular diseases, hypertension, lung cancer, diabetes cerebrovascular disease, muscle weakness, osteoporosis, anxiety and depression.<a href="#bib61" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">28</span></a></p><p class="elsevierStylePara">Results of a large population-based study support the association between COPD and an increased incidence of cardiovascular disease.<a href="#bib62" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">29</span></a></p><p class="elsevierStylePara">Due to the great number and high complexity of diseases associated with COPD we could not comprehensively address all comorbidities. Instead we focused on diabetes and cardiovascular disease since they are common and are associated with an increased frequency of relevant outcomes, including mortality and hospitalizations, in patients with COPD.<a href="#bib40" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">7</span></a></p><p class="elsevierStylePara">The association between respiratory and cardiovascular diseases is a subject of research that has received a great deal of attention in recent years.<a href="#bib63" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">30</span></a><span class="elsevierStyleSup">, </span><a href="#bib64" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">31</span></a><span class="elsevierStyleSup">, </span><a href="#bib65" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">32</span></a><span class="elsevierStyleSup">, </span><a href="#bib66" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">33</span></a> Increased systemic inflammation in COPD patients with cardiac comorbidities supports the hypothesis of systemic inflammation as a potential mechanistic link between COPD and these comorbidities.<a href="#bib61" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">28</span></a></p><p class="elsevierStylePara">The univariate analysis indicated that COPD subjects with one or more comorbidities had a significant higher CAT score than those without comorbidities. This is in agreement with the study of Miyazaki et al.<a href="#bib44" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">11</span></a></p><p class="elsevierStylePara">Burger et al.<a href="#bib60" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">27</span></a> in a cross-sectional study including 326 COPD patients, observed that anxiety and depression, but not cardiovascular disease and diabetes, are associated with low health-related quality of life assessed by SGRQ. In our study there was a lack of association of comorbidities with the SGRQ. The possible explanation is that Saint George is a specific questionnaire for respiratory diseases and does not directly evaluate “activity”, “confidence” and “energy”, items assessed in CAT and which showed strong correlation with functional exercise capacity.</p><p class="elsevierStylePara">The severity of airflow limitation was not generally associated with comorbidities. This result is in agreement with a longitudinal study including 2164 patients, performed by Miller et al.<a href="#bib49" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">16</span></a>, that failed to show association between comorbidities and severity of airflow limitation.</p><p class="elsevierStylePara">Some limitations of this study should be mentioned. This is a cross-sectional study with a convenience sample of patients with moderate to severe COPD. Subjects were recruited from two teaching hospitals and this may differ from COPD patients treated elsewhere. Due to the small sample size, a comparison of sub-groups GOLD stages II, III and IV, was not possible. The participants of this study were treated as considered best by their clinicians, so it was not possible to evaluate the influence of comorbidity treatment on the 6MWT.</p><p class="elsevierStylePara">Some strengths deserve be mentioned. This study used an objective and reproducible method for the assessment of functional exercise capacity (walked distance in the 6MWT) and well-defined criteria for comorbidities. In addition, our patients were homogenously distributed as to the severity of airflow limitation.</p><p class="elsevierStylePara">In summary, the presence of comorbidities contributed to impair functional exercise capacity in the patients studied. This finding reinforces the recommendation for a rigorous search for comorbidities in patients with COPD and functional exercise capacity impairment.</p><a name="sec0040" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Ethical disclosures</span><a name="sec0045" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Protection of human and animal subjects</span><p class="elsevierStylePara">The authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki).</p><a name="sec0050" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Confidentiality of data</span><p class="elsevierStylePara">The authors declare that they have followed the protocols of their work center on the publication of patient data.</p><a name="sec0055" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Right to privacy and informed consent</span><p class="elsevierStylePara">The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.</p><a name="sec0060" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Conflicts of interest</span><p class="elsevierStylePara">The authors have no conflicts of interest to declare.</p><p class="elsevierStylePara">Received 10 November 2014 <br></br>Accepted 1 April 2015 </p><p class="elsevierStylePara">Corresponding author. eanes@fortalnet.com.br</p>" "pdfFichero" => "320v21n05a90436491pdf001.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec640969" "palabras" => array:4 [ 0 => "Exercise capacity" 1 => "Health status" 2 => "COPD" 3 => "Comorbidity" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Background</span><br/><p class="elsevierStylePara">Comorbidities are common in COPD and have been associated with reduced health status, increased health care utilization, all-cause hospitalization, and mortality. There is a scarcity of data on the relationship between comorbidities and functional capacity.</p><span class="elsevierStyleSectionTitle">Objective</span><br/><p class="elsevierStylePara">to evaluate the impact of comorbidities on functional capacity of COPD patients.</p><span class="elsevierStyleSectionTitle">Methods</span><br/><p class="elsevierStylePara">a cross-sectional study was conducted at two teaching hospitals in Fortaleza, Brazil. The functional capacity was assessed by spirometry and the 6-min walking test (6MWT). The health status was assessed by the St. George's respiratory questionnaire (SGRQ) and the COPD assessment test (CAT). The sample was stratified as having “none”, “one” and “two or three” comorbidities groups. One-way ANOVA was used to compare means of the three groups and a multiple linear regression was run to predict the impact of comorbidities on 6MWT.</p><span class="elsevierStyleSectionTitle">Results</span><br/><p class="elsevierStylePara">Comorbidities (hypertension, coronary disease and diabetes) were found in 54% of the studied patients. The mean age of the 79 patients was 67 ± 8 years and 55% were male. CAT scores increased from “no comorbidity” (17.9 ± 7.7) to “one comorbidity” (22.8 ± 6.8) and “two or three comorbidities” groups (24.2 ± 10.2). A post hoc test showed a significant difference in the “no comorbidity” compared to the “two or three comorbidities” groups (<span class="elsevierStyleItalic">p</span> = 0.01). The distance walked by the patients decreased from “no comorbidity” (386.1 ± 83.2 m) to “one comorbidity” (350 ± 98 m) and “two or three comorbidities” groups (312.6 ± 91 m). A post hoc test showed significant difference in the “no comorbidity” compared to “two or three comorbidities” groups (<span class="elsevierStyleItalic">p</span> = 0.007). Numbers of comorbidities were independently associated with the 6MWT adjusting for age, severity of COPD and CAT scores.</p><span class="elsevierStyleSectionTitle">Conclusion</span><br/><p class="elsevierStylePara">in the studied sample, the presence of comorbidities contributed to impair exercise capacity in patients with COPD.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:33 [ 0 => array:3 [ "identificador" => "bib34" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Optimizing economic outcomes in the management of COPD. Int J Chron Obstr Pulm Dis. 2008; 3:1-10." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Optimizing economic outcomes in the management of COPD." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Dal Negro R." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Int J Chron Obstr Pulm Dis. " "fecha" => "2008" "volumen" => "3" "paginaInicial" => "1" "paginaFinal" => "10" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib35" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD. 2008; 5:235-56." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Decramer M" 1 => "Rennard S" 2 => "Troosters T" 3 => "Mapel DW" 4 => "Giardino N" 5 => "Mannino D" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/15412550802237531" "Revista" => array:6 [ "tituloSerie" => "COPD. " "fecha" => "2008" "volumen" => "5" "paginaInicial" => "235" "paginaFinal" => "256" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18671149" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib36" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186:155-61." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Divo M" 1 => "Cote C" 2 => "de Torres JP" 3 => "Casanova C" 4 => "Marin JM" 5 => "Pinto-Plata V" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201201-0034OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med. " "fecha" => "2012" "volumen" => "186" "paginaInicial" => "155" "paginaFinal" => "161" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22561964" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib37" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med. 2011; 5:647-62." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Patel AR" 1 => "Hurst JR." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1586/ers.11.62" "Revista" => array:6 [ "tituloSerie" => "Expert Rev Respir Med. " "fecha" => "2011" "volumen" => "5" "paginaInicial" => "647" "paginaFinal" => "662" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21955235" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib38" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 187:728-35." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Vanfleteren LE" 1 => "Spruit MA" 2 => "Groenen M" 3 => "Gaffron S" 4 => "van Empel VP" 5 => "Bruijnzeel PL" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201209-1665OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med. " "fecha" => "2013" "volumen" => "187" "paginaInicial" => "728" "paginaFinal" => "735" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23392440" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib39" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005; 142:233-323." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Anthonisen NR" 1 => "Skeans MA" 2 => "Wise RA" 3 => "Manfreda J" 4 => "Kanner RE" 5 => "Connett JE." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med. " "fecha" => "2005" "volumen" => "142" "paginaInicial" => "233" "paginaFinal" => "323" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15710956" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib40" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32:962-9." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Mannino DM" 1 => "Thorn D" 2 => "Swensen A" 3 => "Holguin F." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00012408" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J. " "fecha" => "2008" "volumen" => "32" "paginaInicial" => "962" "paginaFinal" => "969" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18579551" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib41" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 176:1208-14." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "McAllister DA" 1 => "Maclay JD" 2 => "Mills NL" 3 => "Mair G" 4 => "Miller J" 5 => "Anderson D" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200707-1080OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med. " "fecha" => "2007" "volumen" => "176" "paginaInicial" => "1208" "paginaFinal" => "1214" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17885263" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib42" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175:1259-65." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Sabit R" 1 => "Bolton CE" 2 => "Edwards PH" 3 => "Pettit RJ" 4 => "Evans WD" 5 => "McEniery CM" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200701-067OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med. " "fecha" => "2007" "volumen" => "175" "paginaInicial" => "1259" "paginaFinal" => "1265" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17363772" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib43" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med. 2009; 179:35-40." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Airflow limitation in smokers is associated with subclinical atherosclerosis." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Iwamoto H" 1 => "Yokoyama A" 2 => "Kitahara Y" 3 => "Ishikawa N" 4 => "Haruta Y" 5 => "Yamane K" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200804-560OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med. " "fecha" => "2009" "volumen" => "179" "paginaInicial" => "35" "paginaFinal" => "40" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18931335" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib44" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014; 15:1-8." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Analysis of comorbid factors that increase the COPD assessment test scores." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Miyazaki M" 1 => "Nakamura H" 2 => "Chubachi S" 3 => "Sasaki M" 4 => "Haraguchi M" 5 => "Yoshida S" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1465-9921-15-1" "Revista" => array:6 [ "tituloSerie" => "Respir Res. " "fecha" => "2014" "volumen" => "15" "paginaInicial" => "1" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24397246" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib45" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006; 47:312-9." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Cully JA" 1 => "Graham DP" 2 => "Stanley MA" 3 => "Ferguson CJ" 4 => "Sharafkhaneh A" 5 => "Souchek J" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1176/appi.psy.47.4.312" "Revista" => array:6 [ "tituloSerie" => "Psychosomatics. " "fecha" => "2006" "volumen" => "47" "paginaInicial" => "312" "paginaFinal" => "319" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16844889" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib46" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000; 41:465-71." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Functional impairment in COPD patients: the impact of anxiety and depression." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Kim HF" 1 => "Kunik ME" 2 => "Molinari VA" 3 => "Hillman SL" 4 => "Lalani S" 5 => "Orengo CA" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1176/appi.psy.41.6.465" "Revista" => array:6 [ "tituloSerie" => "Psychosomatics. " "fecha" => "2000" "volumen" => "41" "paginaInicial" => "465" "paginaFinal" => "471" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11110109" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib47" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res. 2010; 11:29." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Giardino ND" 1 => "Curtis JL" 2 => "Andrei AC" 3 => "Fan VS" 4 => "Benditt JO" 5 => "Lyubkin M" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1465-9921-11-29" "Revista" => array:5 [ "tituloSerie" => "Respir Res. " "fecha" => "2010" "volumen" => "11" "paginaInicial" => "29" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20214820" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib48" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Current perspectives on management of co-morbid depression in COPD. COPD. 2005; 2:185-93." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Current perspectives on management of co-morbid depression in COPD." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Norwood R" 1 => "Balkissoon R." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "COPD. " "fecha" => "2005" "volumen" => "2" "paginaInicial" => "185" "paginaFinal" => "193" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17136980" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib49" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013; 107:1376-84." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Miller J" 1 => "Edwards LD" 2 => "Agustí A" 3 => "Bakke P" 4 => "Calverley PM" 5 => "Celli B" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rmed.2013.05.001" "Revista" => array:6 [ "tituloSerie" => "Respir Med. " "fecha" => "2013" "volumen" => "107" "paginaInicial" => "1376" "paginaFinal" => "1384" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23791463" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib50" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "ATS/ERS task force standardisation of lung function testing: standardisation of spirometry. Eur Respir J. 2005; 26:319-38." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "ATS/ERS task force standardisation of lung function testing: standardisation of spirometry." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Miller MR" 1 => "Hankinson J" 2 => "Brusasco V" 3 => "Burgos F" 4 => "Casaburi R" 5 => "Coates A" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.05.00034805" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J. " "fecha" => "2005" "volumen" => "26" "paginaInicial" => "319" "paginaFinal" => "338" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16055882" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib51" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "American Thoracic Society Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166:111-7." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "American Thoracic Society Statement: guidelines for the six-minute walk test." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/ajrccm.166.1.at1102" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med. " "fecha" => "2002" "volumen" => "166" "paginaInicial" => "111" "paginaFinal" => "117" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12091180" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib52" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The St George's respiratory questionnaire. Respir Med. 1991; 85(Suppl. B):25-31." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The St George's respiratory questionnaire." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Jones PW" 1 => "Quirk FH" 2 => "Baveystock CM." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Respir Med. " "fecha" => "1991" "volumen" => "85" "paginaInicial" => "25" "paginaFinal" => "31" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1759018" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib53" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34:648-54." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Development and first validation of the COPD Assessment Test." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Jones PW" 1 => "Harding G" 2 => "Berry P" 3 => "Wiklund I" 4 => "Chen W-H" 5 => "Leidy NK." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00102509" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J. " "fecha" => "2009" "volumen" => "34" "paginaInicial" => "648" "paginaFinal" => "654" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19720809" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib54" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Validação do Questionário do Hospital Saint George na Doença Respiratória (SGRQ) em pacientes portadores de Doença Pulmonar Obstrutiva Crônica no Brasil. Braz J Pneumol. 2000; 26:119-25." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Validação do Questionário do Hospital Saint George na Doença Respiratória (SGRQ) em pacientes portadores de Doença Pulmonar Obstrutiva Crônica no Brasil." "idioma" => "pt" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Sousa TC" 1 => "Jardim JR" 2 => "Jones P." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Braz J Pneumol. " "fecha" => "2000" "volumen" => "26" "paginaInicial" => "119" "paginaFinal" => "125" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib55" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Comparison of face-to-face interview and telephone interview administration of COPD assessment test: a randomized study. Qual Life Res. 2014; 23:1193-7." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Comparison of face-to-face interview and telephone interview administration of COPD assessment test: a randomized study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "da Silva GF" 1 => "Morano MT" 2 => "Sales MP" 3 => "Olegário NB" 4 => "Cavalcante AG" 5 => "Pereira ED." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11136-013-0563-x" "Revista" => array:6 [ "tituloSerie" => "Qual Life Res. " "fecha" => "2014" "volumen" => "23" "paginaInicial" => "1193" "paginaFinal" => "1197" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24178631" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib56" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Validação do teste de avaliação da DPOC em português para uso no brasil. J Bras Pneumol. 2013; 39:402-8." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Validação do teste de avaliação da DPOC em português para uso no brasil." "idioma" => "pt" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Silva GP" 1 => "Morano MT" 2 => "Viana CS" 3 => "Magalhães CB" 4 => "Pereira ED." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/S1806-37132013000400002" "Revista" => array:6 [ "tituloSerie" => "J Bras Pneumol. " "fecha" => "2013" "volumen" => "39" "paginaInicial" => "402" "paginaFinal" => "408" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24068260" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib57" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The Global Initiative for Chronic Obstructive Lung disease (GOLD). Executive summary: global strategy for the diagnosis, management, and prevention of COPD. 2014. Updated 2014, available from <inter-ref>www.goldcopd.com</inter-ref>" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Global Initiative for Chronic Obstructive Lung disease (GOLD). Executive summary: global strategy for the diagnosis, management, and prevention of COPD." "idioma" => "en" ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:2 [ "titulo" => "The Global Initiative for Chronic Obstructive Lung disease (GOLD). Executive summary: global strategy for the diagnosis, management, and prevention of COPD." "fecha" => "2014" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib58" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008; 63:487-92." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Crisafulli E" 1 => "Costi S" 2 => "Luppi F" 3 => "Cirelli G" 4 => "Cilione C" 5 => "Coletti O" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thx.2007.086371" "Revista" => array:6 [ "tituloSerie" => "Thorax. " "fecha" => "2008" "volumen" => "63" "paginaInicial" => "487" "paginaFinal" => "492" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18203818" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib59" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350:1005-12." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Celli BR" 1 => "Cote CG" 2 => "Marin JM" 3 => "Casanova C" 4 => "Montes de Oca M" 5 => "Mendez RA" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa021322" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med. " "fecha" => "2004" "volumen" => "350" "paginaInicial" => "1005" "paginaFinal" => "1012" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14999112" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib60" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013; 107:233-41." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Impact of comorbidities on COPD-specific health-related quality of life." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:8 [ 0 => "Burgel PR" 1 => "Escamilla R" 2 => "Perez T" 3 => "Carré P" 4 => "Caillaud D" 5 => "Chanez P" 6 => "et-al" 7 => "INITIATIVES BPCO Scientific Committee." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rmed.2012.10.002" "Revista" => array:6 [ "tituloSerie" => "Respir Med. " "fecha" => "2013" "volumen" => "107" "paginaInicial" => "233" "paginaFinal" => "241" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23098687" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib61" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013; 1:73-83." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Chronic obstructive pulmonary disease and comorbidities." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Decramer M" 1 => "Janssens W." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(12)70060-7" "Revista" => array:6 [ "tituloSerie" => "Lancet Respir Med. " "fecha" => "2013" "volumen" => "1" "paginaInicial" => "73" "paginaFinal" => "83" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24321806" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib62" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010; 65:956-62." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Feary JR" 1 => "Rodrigues LC" 2 => "Smith CJ" 3 => "Hubbard RB" 4 => "Gibson JE." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thx.2009.128082" "Revista" => array:6 [ "tituloSerie" => "Thorax. " "fecha" => "2010" "volumen" => "65" "paginaInicial" => "956" "paginaFinal" => "962" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20871122" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib63" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006; 16:63-70." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Curkendall SM" 1 => "DeLuise C" 2 => "Jones JK" 3 => "Lanes S" 4 => "Stang MR" 5 => "Goehring E" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.annepidem.2005.04.008" "Revista" => array:6 [ "tituloSerie" => "Ann Epidemiol. " "fecha" => "2006" "volumen" => "16" "paginaInicial" => "63" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16039877" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib64" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007; 49:171-80." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Le Jemtel TH" 1 => "Padeletti M" 2 => "Jelic S." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2006.08.046" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol. " "fecha" => "2007" "volumen" => "49" "paginaInicial" => "171" "paginaFinal" => "180" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17222727" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib65" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Stroke. 2002; 33:2170-6." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Kiechl S" 1 => "Werner P" 2 => "Egger G" 3 => "Oberhollenzer F" 4 => "Mayr M" 5 => "Xu Q" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Stroke. " "fecha" => "2002" "volumen" => "33" "paginaInicial" => "2170" "paginaFinal" => "2176" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12215582" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib66" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg. 2006; 131:43-53." "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Naunheim KS" 1 => "Wood DE" 2 => "Krasna MJ" 3 => "DeCamp MM" 4 => "Ginsburg ME" 5 => "McKenna RJ" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jtcvs.2005.09.006" "Revista" => array:6 [ "tituloSerie" => "J Thorac Cardiovasc Surg. " "fecha" => "2006" "volumen" => "131" "paginaInicial" => "43" "paginaFinal" => "53" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16399293" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/08732159/0000002100000005/v0_201604141143/X0873215915364914/v0_201604141143/en/main.assets" "Apartado" => array:4 [ "identificador" => "18133" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Artigos originais" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/08732159/0000002100000005/v0_201604141143/X0873215915364914/v0_201604141143/en/320v21n05a90436491pdf001.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915364914?idApp=UINPBA00004E" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 10 | 7 | 17 |
2024 October | 59 | 40 | 99 |
2024 September | 52 | 28 | 80 |
2024 August | 70 | 30 | 100 |
2024 July | 110 | 36 | 146 |
2024 June | 67 | 21 | 88 |
2024 May | 71 | 35 | 106 |
2024 April | 66 | 33 | 99 |
2024 March | 65 | 28 | 93 |
2024 February | 76 | 17 | 93 |
2024 January | 58 | 27 | 85 |
2023 December | 47 | 26 | 73 |
2023 November | 45 | 34 | 79 |
2023 October | 54 | 49 | 103 |
2023 September | 43 | 35 | 78 |
2023 August | 46 | 16 | 62 |
2023 July | 48 | 29 | 77 |
2023 June | 45 | 12 | 57 |
2023 May | 77 | 31 | 108 |
2023 April | 59 | 25 | 84 |
2023 March | 130 | 21 | 151 |
2023 February | 87 | 33 | 120 |
2023 January | 46 | 21 | 67 |
2022 December | 72 | 17 | 89 |
2022 November | 118 | 46 | 164 |
2022 October | 99 | 34 | 133 |
2022 September | 67 | 29 | 96 |
2022 August | 70 | 36 | 106 |
2022 July | 65 | 48 | 113 |
2022 June | 51 | 34 | 85 |
2022 May | 65 | 45 | 110 |
2022 April | 55 | 36 | 91 |
2022 March | 82 | 56 | 138 |
2022 February | 88 | 37 | 125 |
2022 January | 76 | 34 | 110 |
2021 December | 50 | 42 | 92 |
2021 November | 51 | 37 | 88 |
2021 October | 67 | 58 | 125 |
2021 September | 45 | 22 | 67 |
2021 August | 55 | 27 | 82 |
2021 July | 65 | 24 | 89 |
2021 June | 78 | 29 | 107 |
2021 May | 95 | 48 | 143 |
2021 April | 233 | 126 | 359 |
2021 March | 160 | 26 | 186 |
2021 February | 128 | 35 | 163 |
2021 January | 97 | 21 | 118 |
2020 December | 70 | 15 | 85 |
2020 November | 102 | 27 | 129 |
2020 October | 92 | 21 | 113 |
2020 September | 95 | 28 | 123 |
2020 August | 111 | 30 | 141 |
2020 July | 130 | 31 | 161 |
2020 June | 100 | 28 | 128 |
2020 May | 118 | 24 | 142 |
2020 April | 89 | 12 | 101 |
2020 March | 87 | 13 | 100 |
2020 February | 87 | 19 | 106 |
2020 January | 88 | 20 | 108 |
2019 December | 95 | 22 | 117 |
2019 November | 59 | 18 | 77 |
2019 October | 74 | 14 | 88 |
2019 September | 73 | 16 | 89 |
2019 August | 206 | 25 | 231 |
2019 July | 252 | 16 | 268 |
2019 June | 241 | 18 | 259 |
2019 May | 235 | 17 | 252 |
2019 April | 250 | 20 | 270 |
2019 March | 304 | 14 | 318 |
2019 February | 272 | 8 | 280 |
2019 January | 309 | 27 | 336 |
2018 December | 70 | 11 | 81 |
2018 November | 88 | 2 | 90 |
2018 October | 104 | 14 | 118 |
2018 September | 28 | 8 | 36 |
2018 August | 40 | 31 | 71 |
2018 July | 42 | 19 | 61 |
2018 June | 50 | 16 | 66 |
2018 May | 56 | 16 | 72 |
2018 April | 100 | 35 | 135 |
2018 March | 45 | 16 | 61 |
2018 February | 8 | 9 | 17 |
2018 January | 13 | 13 | 26 |
2017 December | 19 | 23 | 42 |
2017 November | 16 | 19 | 35 |
2017 October | 21 | 14 | 35 |
2017 September | 14 | 22 | 36 |
2017 August | 19 | 17 | 36 |
2017 July | 15 | 14 | 29 |
2017 June | 16 | 14 | 30 |
2017 May | 17 | 21 | 38 |
2017 April | 9 | 3 | 12 |
2017 March | 6 | 11 | 17 |
2017 February | 7 | 9 | 16 |
2017 January | 13 | 10 | 23 |
2016 December | 12 | 9 | 21 |
2016 November | 10 | 7 | 17 |
2016 October | 7 | 15 | 22 |
2016 September | 5 | 6 | 11 |
2016 August | 11 | 11 | 22 |
2016 July | 9 | 10 | 19 |
2016 June | 0 | 30 | 30 |
2016 May | 1 | 8 | 9 |
2016 April | 21 | 18 | 39 |
2016 March | 37 | 18 | 55 |
2016 February | 45 | 24 | 69 |
2016 January | 36 | 18 | 54 |
2015 December | 93 | 51 | 144 |
2015 November | 92 | 54 | 146 |
2015 October | 133 | 83 | 216 |
2015 September | 190 | 134 | 324 |